PHARMACY

​​​​​​​Cimerli is the first and only FDA-approved biosimilar interchangeable with Lucentis (ranibizumab injection).

Clinical audit programs prevent waste, improve adherence, reduce spend and provide outcomes data, the company said.

CVS Health has seen a 15.7% reduction in suicide attempts among Aetna members through March 2022 compared to 2019 baselines.

The collaboration is part of Upsher-Smith’s effort to grow its portfolio of products through strategic partnerships and product acquisitions.

The company is offering bortezomib for injection 3.5 mg and ulvestrant injection 250 mg/5 ml.

WBA is acquiring the remaining 30% stake of Shields (approximately 35% on a fully diluted basis) for approximately $1.37 billion.

The Avalere analysis shows that generic drugs continue to be misplaced on higher formulary tiers, unfairly driving up costs for patients.

Tandon, chief clinical trials officer at Walgreens, discusses the company’s decision to launch its clinical trial business.

The NACDS RxIMPACT Votes event will provide information about the 2022 elections and what they expect for the future of pharmacy.

The acquisition aligns with McKesson’s strategic growth focus by connecting biopharma and payer services to patients, the company said.

Sotyktu is an oral treatment for adults with moderate-to-severe plaque psoriasis.

Xifaxan 200 mg is indicated for travelers' diarrhea and currently contributes less than 1% of Salix’s revenues.

Imfinzi is used to treat adult patients with locally advanced or metastatic biliary tract cancer in combination with chemotherapy (gemcitabine plus cisplatin).

Routine vaccinations and immunizations are available at select Rite Aid and Bartell Drugs locations on weekdays after work and on the weekends.

Dr. Reddy’s is eligible for first to market, 180 days of generic drug exclusivity for lenalidomide capsules in 2.5-mg and 20-mg strengths.

Generic Faslodex is used to treat advanced-stage, hormone receptor-positive, HER2-negative breast cancer.

Konvomep is approved for the treatment of active benign gastric ulcer and reduction of risk of upper gastrointestinal bleeding in critically ill patients.

The foundation has released a request for proposals opportunity to award up to $1.5 million in new research.

Spevigo is the first approved treatment option for generalized pustular psoriasis flares in adults.

​​​​​​​All 213 CVS Pharmacy locations across Louisiana, Mississippi and Arkansas are now using time-delay safe technology.

Epiduo Forte is indicated for the topical treatment of acne vulgaris in adults and pediatric patients aged 12 years old and older.

The parties will work toward ensuring access to drugs at affordable prices to patients in need.

Convenient care clinics continue to expand their offerings and their appeal to consumers.

The cloud-based solution aims to streamline retail pharmacists’ workflow to give them quality time to spend with patients.